temozolomide has been researched along with Cytomegalovirus Infections in 11 studies
Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Temozolomide, a key drug in the treatment of malignant glioma, can cause profound lymphopenia and various opportunistic infectious diseases." | 7.88 | Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide. ( Furukawa, R; Homma, H; Horiuchi, H; Inoue, T; Usui, K, 2018) |
| "Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia." | 7.74 | Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. ( Baden, LR; Kulke, MH; Michelini, A; Schwarzberg, AB; Sengupta, T; Stover, EH; Vincitore, M, 2007) |
| "Treatment of malignant gliomas has changed substantially over the last few years." | 5.35 | Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. ( Benekli, M; Buyukberber, N; Buyukberber, S; Coskun, O; Coskun, U; Kaya, AO; Ozturk, B; Yaman, E; Yildiz, R, 2009) |
| "Temozolomide chemotherapy has become part of the therapy used to treat glioblastoma multiforme and refractory anaplastic astrocytoma." | 4.86 | Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review. ( Aguado, JM; García-Reyne, A; Juan, RS; Lalueza, A; Lizasoain, M; López-Medrano, F; Martínez, P; Meije, Y; Rodríguez, V, 2010) |
| " Following tumor resection, the patient underwent concomitant radiation and temozolomide therapy that was complicated by CMV colitis and abdominal abscesses." | 3.91 | Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report. ( Bloch, O; Grimm, SA; Horbinski, CM; Kumthekar, PU; Lamano, JB; Quaggin-Smith, JA; Tate, MC, 2019) |
| "Temozolomide, a key drug in the treatment of malignant glioma, can cause profound lymphopenia and various opportunistic infectious diseases." | 3.88 | Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide. ( Furukawa, R; Homma, H; Horiuchi, H; Inoue, T; Usui, K, 2018) |
| "Temozolomide is utilized as a treatment for a variety of solid tumors and has been associated with the development of selective lymphopenia." | 3.74 | Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide. ( Baden, LR; Kulke, MH; Michelini, A; Schwarzberg, AB; Sengupta, T; Stover, EH; Vincitore, M, 2007) |
| "Treatment of malignant gliomas has changed substantially over the last few years." | 1.35 | Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. ( Benekli, M; Buyukberber, N; Buyukberber, S; Coskun, O; Coskun, U; Kaya, AO; Ozturk, B; Yaman, E; Yildiz, R, 2009) |
| "We report the case of a patient with primary brain tumor who developed cytomegalovirus associated colonic pseudotumor as an opportunistic infection while receiving chemotherapy with Temozolomide and radiation." | 1.35 | Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. ( De Jesus, A; Grossman, SA; Paun, O, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, P | 1 |
| Neumann, DM | 1 |
| Weathers, SP | 1 |
| Penas-Prado, M | 1 |
| Pei, BL | 1 |
| Ling, X | 1 |
| Kassab, C | 1 |
| Banerjee, P | 1 |
| Bdiwi, M | 1 |
| Shaim, H | 1 |
| Alsuliman, A | 1 |
| Shanley, M | 1 |
| de Groot, JF | 1 |
| O'Brien, BJ | 1 |
| Harrison, R | 1 |
| Majd, N | 1 |
| Kamiya-Matsuoka, C | 1 |
| Fuller, GN | 1 |
| Huse, JT | 1 |
| Chi, L | 1 |
| Rao, G | 1 |
| Weinberg, JS | 1 |
| Lang, FF | 1 |
| Sawaya, R | 1 |
| Shpall, EJ | 1 |
| Rezvani, K | 1 |
| Heimberger, AB | 2 |
| Furukawa, R | 1 |
| Homma, H | 1 |
| Inoue, T | 1 |
| Horiuchi, H | 1 |
| Usui, K | 1 |
| Lamano, JB | 1 |
| Quaggin-Smith, JA | 1 |
| Horbinski, CM | 1 |
| Tate, MC | 1 |
| Grimm, SA | 1 |
| Kumthekar, PU | 1 |
| Bloch, O | 1 |
| Ferguson, SD | 1 |
| Srinivasan, VM | 1 |
| Ghali, MG | 1 |
| Yaman, E | 1 |
| Coskun, U | 1 |
| Ozturk, B | 1 |
| Buyukberber, S | 1 |
| Kaya, AO | 1 |
| Coskun, O | 1 |
| Buyukberber, N | 1 |
| Yildiz, R | 1 |
| Benekli, M | 1 |
| De Jesus, A | 1 |
| Grossman, SA | 1 |
| Paun, O | 1 |
| Gousias, K | 1 |
| Konstantinos, G | 1 |
| Kyritsis, A | 1 |
| Athanasios, K | 1 |
| Meije, Y | 1 |
| Lizasoain, M | 1 |
| García-Reyne, A | 1 |
| Martínez, P | 1 |
| Rodríguez, V | 1 |
| López-Medrano, F | 1 |
| Juan, RS | 1 |
| Lalueza, A | 1 |
| Aguado, JM | 1 |
| Okita, Y | 1 |
| Narita, Y | 1 |
| Miyakita, Y | 1 |
| Ohno, M | 1 |
| Nagai, S | 1 |
| Shibui, S | 1 |
| Schwarzberg, AB | 1 |
| Stover, EH | 1 |
| Sengupta, T | 1 |
| Michelini, A | 1 |
| Vincitore, M | 1 |
| Baden, LR | 1 |
| Kulke, MH | 1 |
2 reviews available for temozolomide and Cytomegalovirus Infections
| Article | Year |
|---|---|
Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
Topics: Animals; Brain Neoplasms; Cytomegalovirus; Cytomegalovirus Infections; Dacarbazine; Glioblastoma; Hu | 2016 |
Emergence of cytomegalovirus disease in patients receiving temozolomide: report of two cases and literature review.
Topics: Aged; Antineoplastic Agents, Alkylating; Central Nervous System Neoplasms; Cytomegalovirus Infection | 2010 |
1 trial available for temozolomide and Cytomegalovirus Infections
| Article | Year |
|---|---|
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Topics: Adult; CD8-Positive T-Lymphocytes; Cytomegalovirus; Cytomegalovirus Infections; Female; Glioblastoma | 2020 |
8 other studies available for temozolomide and Cytomegalovirus Infections
| Article | Year |
|---|---|
Persistent HCMV infection of a glioblastoma cell line contributes to the development of resistance to temozolomide.
Topics: Antineoplastic Agents, Alkylating; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytomegalovi | 2020 |
Cytomegalovirus Hemorrhagic Cystitis in a Malignant Glioma Patient Treated with Temozolomide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antiviral Agents; Cystitis; Cytomegalovirus Infectio | 2018 |
Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report.
Topics: Aged; Brain Neoplasms; Chemoradiotherapy; Colitis; Cytomegalovirus Infections; Female; Glioblastoma; | 2019 |
Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma.
Topics: Administration, Oral; Antineoplastic Agents, Alkylating; Cytomegalovirus Infections; Dacarbazine; DN | 2009 |
Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cytomegalovirus Infections; Dacarbazine; F | 2009 |
Comment on "Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma".
Topics: Antineoplastic Agents, Alkylating; Cytomegalovirus Infections; Dacarbazine; Glioma; Humans; Opportun | 2010 |
Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cytomegalovirus; | 2012 |
Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Cytomegalovirus Infections; Dacarbazine; Female; Her | 2007 |